Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit

Standard

Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit. / Blome, Christine; Radtke, Marc A; Eissing, Leah; Augustin, Matthias.

In: AM J CLIN DERMATOL, Vol. 17, No. 2, 04.2016, p. 163-169.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{100343d0a49d4379b9875e9d0f534db8,
title = "Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit",
abstract = "Health-related quality of life (HRQoL) is often markedly impaired in both adults and children with atopic dermatitis. The quality of life of the parents of infants or children with this chronic disease is also affected owing to problems such as itch-induced sleeping problems and treatment effort. As HRQoL is only partly associated with disease severity, both parameters should be evaluated in research and clinical practice. For the measurement of HRQoL, both skin- and disease-specific questionnaires are available in addition to generic instruments. In randomized controlled trials on atopic dermatitis, HRQoL is most commonly evaluated with the Dermatology Life Quality Index for use in adults and related questionnaires for children and families, such as the Children's Dermatology Life Quality Index. There is evidence that different treatment modalities may be effective in improving HRQoL in adults, children, and parents, which is supported by the patients' own evaluation of treatment benefit in an observational study.",
keywords = "Adult, Child, Climatotherapy, Cost of Illness, Dermatitis, Atopic, Female, Glucocorticoids, Humans, Immunosuppressive Agents, Infant, Male, Observational Studies as Topic, Probiotics, Quality of Life, Randomized Controlled Trials as Topic, Severity of Illness Index, Surveys and Questionnaires, Treatment Outcome, Journal Article, Review",
author = "Christine Blome and Radtke, {Marc A} and Leah Eissing and Matthias Augustin",
year = "2016",
month = apr,
doi = "10.1007/s40257-015-0171-3",
language = "English",
volume = "17",
pages = "163--169",
journal = "AM J CLIN DERMATOL",
issn = "1175-0561",
publisher = "Adis International Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit

AU - Blome, Christine

AU - Radtke, Marc A

AU - Eissing, Leah

AU - Augustin, Matthias

PY - 2016/4

Y1 - 2016/4

N2 - Health-related quality of life (HRQoL) is often markedly impaired in both adults and children with atopic dermatitis. The quality of life of the parents of infants or children with this chronic disease is also affected owing to problems such as itch-induced sleeping problems and treatment effort. As HRQoL is only partly associated with disease severity, both parameters should be evaluated in research and clinical practice. For the measurement of HRQoL, both skin- and disease-specific questionnaires are available in addition to generic instruments. In randomized controlled trials on atopic dermatitis, HRQoL is most commonly evaluated with the Dermatology Life Quality Index for use in adults and related questionnaires for children and families, such as the Children's Dermatology Life Quality Index. There is evidence that different treatment modalities may be effective in improving HRQoL in adults, children, and parents, which is supported by the patients' own evaluation of treatment benefit in an observational study.

AB - Health-related quality of life (HRQoL) is often markedly impaired in both adults and children with atopic dermatitis. The quality of life of the parents of infants or children with this chronic disease is also affected owing to problems such as itch-induced sleeping problems and treatment effort. As HRQoL is only partly associated with disease severity, both parameters should be evaluated in research and clinical practice. For the measurement of HRQoL, both skin- and disease-specific questionnaires are available in addition to generic instruments. In randomized controlled trials on atopic dermatitis, HRQoL is most commonly evaluated with the Dermatology Life Quality Index for use in adults and related questionnaires for children and families, such as the Children's Dermatology Life Quality Index. There is evidence that different treatment modalities may be effective in improving HRQoL in adults, children, and parents, which is supported by the patients' own evaluation of treatment benefit in an observational study.

KW - Adult

KW - Child

KW - Climatotherapy

KW - Cost of Illness

KW - Dermatitis, Atopic

KW - Female

KW - Glucocorticoids

KW - Humans

KW - Immunosuppressive Agents

KW - Infant

KW - Male

KW - Observational Studies as Topic

KW - Probiotics

KW - Quality of Life

KW - Randomized Controlled Trials as Topic

KW - Severity of Illness Index

KW - Surveys and Questionnaires

KW - Treatment Outcome

KW - Journal Article

KW - Review

U2 - 10.1007/s40257-015-0171-3

DO - 10.1007/s40257-015-0171-3

M3 - SCORING: Journal article

C2 - 26818063

VL - 17

SP - 163

EP - 169

JO - AM J CLIN DERMATOL

JF - AM J CLIN DERMATOL

SN - 1175-0561

IS - 2

ER -